Iowa Diabetes and Endocrinology Research Center (IDERC) 
has board certified endocrinologists, who are passionate about diabetes research. We have ongoing studies that focus on research involving newer agents (oral medication, injectable medications or insulins) directly affecting blood sugar control.

NEWS:

IDERC joins the first of it's kind global study!

Featured Studies:

Do you have Type 2 diabetes and have a history of heart disease?
Are your sugars not in control?

The study involves the use of a diabetes medication called Januvia or placebo in patients with type 2 diabetes with a history of heart or vascular disease (example heart attacks, procedures for heart attacks, strokes or peripheral vascular disease).

The duration of this study will be about 4 years (may vary from 3 to 6 years depending on time of your enrollment and progress of the study). You will visit the study doctor 4 times in the first year and 2 times a year afterwards. 

To participate in the study, you should:

• Be ≥ 50 years of age
• Not be using insulin currently
• Have a HbA1c of ≥ 6.5% and ≤ 8.0% (within the past 3 months)

If you qualify, you will receive study related care and study medication(s) at no charge. You will also receive compensation for travel expenses.

Consent                    Clinical Trial             

---

Do you have type 2 diabetes and are taking pioglitazone and metformin? Are your sugars not in control?

This study involves patients with Type 2 diabetes. Study participants will have 11 visits over 1 year with a possibility to continue treatment for another six months during the extension phase (for a total of approximately one year of treatment).

To participate in the study, you should:
    Be between 18-75 years of age
    Have not taken insulin for longer than one week during the past six months

If you qualify, you will receive study-related care and study medication(s) at no charge. You will also receive compensation for travel expenses.

Consent                    Clinical Trial